Literature DB >> 26160351

Stem Cell Depletion by Global Disorganization of the H3K9me3 Epigenetic Marker in Aging.

Andrew R Mendelsohn1, James W Larrick1.   

Abstract

Epigenomic change and stem cell exhaustion are two of the hallmarks of aging. Accumulation of molecular damage is thought to underlie aging, but the precise molecular composition of the damage remains controversial. That some aging phenotypes, especially those that result from impaired stem cell function, are reversible suggest that such "damage" is repairable. Evidence is accumulating that dysfunction in aging stem cells results from increasing, albeit, subtle disorganization of the epigenome over time. Zhang et al. (2015) report that decreasing levels of WRN, Werner's syndrome (WS) helicase, with increasing age results in loss of heterochromatin marks in mesenchymal stem cells (MSCs) and correlates with an increased rate of cellular senescence. Although WRN plays a role in DNA repair, WRN exerted its effects on aging via maintaining heterochromatin, evidenced by reduced levels of interacting chromatin regulators heterochromatin protein 1α (HP1α), suppressor of variegation 3-9 homolog 1 (SUV39H1), and lamina-associated polypeptide 2β (LAP2β) as well as modified histone H3K9me3. Reducing expression of chromatin modeling co-factors SUV39H1 or HP1α in wild-type MSCs recapitulates the phenotype of WRN deficiency, resulting in reduced H3K9me3 levels and increased senescence without induction of markers of DNA damage, suggesting that chromatin disorganization and not DNA damage is responsible for the pathology of WS during aging in animals. Ectopic expression of HP1α restored H3K9me3 levels and repressed senescence in WRN-deficient MSCs. That HP1α can also suppress senescence in Hutchinson-Gilford progeria syndrome (HGPS) and extend life span in flies when over-expressed suggests that HP1α and H3K9me3 play conserved roles in maintenance of cell state. H3K9me3 levels are dynamic and expected to be potentially responsive to manipulation by extrinsic factors. Recent reports that migration inhibitory factor (MIF) or periodic fasting rejuvenate old MSCs provide the opportunity to link intrinsic and extrinsic mechanisms of aging in novel and potentially medically important ways and may lead to anti-aging treatments that reorganize the epigenome to rejuvenate cells and tissues.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26160351     DOI: 10.1089/rej.2015.1742

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  6 in total

1.  The Antiaging Gene Klotho Regulates Proliferation and Differentiation of Adipose-Derived Stem Cells.

Authors:  Jun Fan; Zhongjie Sun
Journal:  Stem Cells       Date:  2016-02-26       Impact factor: 6.277

Review 2.  The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia.

Authors:  Laura Monaghan; Matthew E Massett; Roderick P Bunschoten; Alex Hoose; Petrisor-Alin Pirvan; Robert M J Liskamp; Heather G Jørgensen; Xu Huang
Journal:  Front Oncol       Date:  2019-08-02       Impact factor: 6.244

3.  Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A.

Authors:  So-Mi Kang; Min-Ho Yoon; Su-Jin Lee; Jinsook Ahn; Sang Ah Yi; Ki Hong Nam; Soyoung Park; Tae-Gyun Woo; Jung-Hyun Cho; Jaecheol Lee; Nam-Chul Ha; Bum-Joon Park
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

4.  Global Gene Expression Regulation Mediated by TGFβ Through H3K9me3 Mark.

Authors:  Ankit Naik; Nidhi Dalpatraj; Noopur Thakur
Journal:  Cancer Inform       Date:  2022-07-30

5.  DONSON and FANCM associate with different replisomes distinguished by replication timing and chromatin domain.

Authors:  Jing Zhang; Marina A Bellani; Ryan C James; Durga Pokharel; Yongqing Zhang; John J Reynolds; Gavin S McNee; Andrew P Jackson; Grant S Stewart; Michael M Seidman
Journal:  Nat Commun       Date:  2020-08-07       Impact factor: 14.919

6.  Bioinformatics analysis of the network of histone H3 lysine 9 trimethylation in acute myeloid leukaemia.

Authors:  Aishu Dong; Wenbin Yang; He Huang; Xiaohai Zhou; Zhewei He; Rongxing Yao; Wenjian Guo
Journal:  Oncol Rep       Date:  2020-05-28       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.